Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

175 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Nicotinic treatment for cognitive dysfunction.
Levin ED, Rezvani AH. Levin ED, et al. Among authors: rezvani ah. Curr Drug Targets CNS Neurol Disord. 2002 Aug;1(4):423-31. doi: 10.2174/1568007023339102. Curr Drug Targets CNS Neurol Disord. 2002. PMID: 12769614 Review.
Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D1 receptor antagonist SCH-23390 or the serotonin 5-HT2C agonist lorcaserin.
DiPalma D, Rezvani AH, Willette B, Wells C, Slade S, Hall BJ, Levin ED. DiPalma D, et al. Among authors: rezvani ah. Pharmacol Biochem Behav. 2019 Jan;176:16-22. doi: 10.1016/j.pbb.2018.11.002. Epub 2018 Nov 9. Pharmacol Biochem Behav. 2019. PMID: 30419272 Free PMC article.
175 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page